Radiation therapy (RT) plays an important curative role in patients with locally advanced cervical cancer. Optimal treatment depends on strong, multidisciplinary programmatic support and availability of specialized skills. There is evidence that the quality of care provided to patients with cervical cancer can impact clinical outcomes. However, there is little agreement as to what constitutes best practice, especially in the face of a rapidly changing treatment landscape with increasing emphasis on new imaging modalities and brachytherapy (BT) approaches. The purpose of this study was to develop a suite of RT quality of care indicators (QIs) for the curative management of locally advanced cervical cancer to guide assessment of individual programmatic performance and motivate harmonization of practice. A modified-Delphi method was used. A comprehensive literature search was conducted to identify candidate QIs. These were reviewed for clarity and completeness by a steering panel. QIs were categorized as: Pre-treatment assessment, External beam RT, BT, Follow-up and Expertise/Workload. Next, all Canadian radiation oncologists (ROs) who treat gynecological malignancies were surveyed and rated the importance of each QI from 0-9 (9, essential) on a Likert scale, and the achievability in their center on a binary scale (yes/no). Some QIs were deemed aspirational, and the predicted importance and achievability in 5 years were also scored. Results were analyzed by calculating mean importance scores and by using previously validated, pre-specified criteria for endorsement. A face-to-face Delphi meeting will take place late Feb 2014 with a group of identified, expert ROs, facilitated by an outside moderator. This will yield a suite of high-importance QIs that will comprise a consensus guideline for quality RT. A total of 54 ROs responded to the survey (70%). Of the candidate 83 QIs, 44 met the specified criteria for endorsement. Mean importance scores ranged from 2.1 (use of Smit sleeve) to 8.9 (utilization of BT). Twenty-four indicators were deemed ‘essential’ by at least 50% of respondents. Of the 44 highest rated QIs, 14 were from pre-treatment assessment, 15 from external beam RT, 7 from BT, 4 from follow-up and 4 from expertise/workload. Of the 14 aspirational indicators, 3 met specified criteria currently and 4 were predicted to meet criteria within 5 years. The results of the Delphi meeting, based on the survey findings, and the final suite of QIs will also be reported. This is the first prospective study to develop RT quality of care indicators in locally advanced cervix cancer based on expert consensus. These QIs will provide a foundation for programmatic self-assessment and quality improvement aimed at ensuring consistent and optimal treatment of patients with this disease.